Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DMAC - Yatsen Holding CytomX Therapeutics among premarket losers' pack

DMAC - Yatsen Holding CytomX Therapeutics among premarket losers' pack

July, 07 2022 08:19 AM DiaMedica Therapeutics Inc.

DiaMedica Therapeutics ( DMAC ) -35% after FDA puts DiaMedica's phase 2/3 trial for its stroke treatment DM199 on clinical hold .
CytomX Therapeutics ( CTMX ) -27% on phase 2 study of breast cancer antibody praluzatamab .
Yatsen Holding ( YSG ) -10% .
HTG Molecular Diagnostics ( HTGM ) -7% .
Revelation Biosciences ( REVB ) -6% .

For further details see:

Yatsen Holding, CytomX Therapeutics among premarket losers' pack

Stock Information

Company Name:	DiaMedica Therapeutics Inc.
Stock Symbol:	DMAC
Market:	NASDAQ
Website:	diamedica.com

DMAC DMAC Quote DMAC Short DMAC News DMAC Articles DMAC Message Board

Get DMAC Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.